Production (Stage)
IO Biotech, Inc.
IOBT
$1.50
-$0.10-6.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.13% | -8.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.18% | 1.66% | |||
| Operating Income | 16.18% | -1.66% | |||
| Income Before Tax | 27.88% | -29.75% | |||
| Income Tax Expenses | -67.19% | 112.92% | |||
| Earnings from Continuing Operations | 28.44% | -30.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.44% | -30.47% | |||
| EBIT | 16.18% | -1.66% | |||
| EBITDA | 16.21% | -1.65% | |||
| EPS Basic | 28.45% | -30.48% | |||
| Normalized Basic EPS | 27.88% | -29.76% | |||
| EPS Diluted | 28.45% | -30.48% | |||
| Normalized Diluted EPS | 27.88% | -29.76% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||